When an influential federal panel recommended in 2012 that doctors omit prostate cancer screening from routine health care, it set off a firestorm.
The advice of the U.S. Preventive Services Task Force appears to have led to a sizable drop in screening with the PSA blood test, and in diagnosis of early-stage prostate cancer, according to American Cancer Society researchers who have been monitoring the trends. They also found that the rates of advanced prostate cancer diagnoses have remained stable - at least, so far.
Read Full Article »